This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.
The drug FLUSORT contains one active pharmaceutical ingredient (API):
1
|
UNII
O2GMZ0LF5W - FLUTICASONE PROPIONATE
|
|
Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-3688 | Spray, Metered-Dose | Flusort Nasal Spray SPRAY_MET 50 mcg/Metered-Dose 15 mL | Aqueous suspension of 0.05% w/w micronized fluticasone propionate. For intranasal inhalation via metered dose atomizing pump. Each metered dose contains: Fluticasone propionate 50 micrograms | 01/03/2021 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 63319 |
| NG | Registered Drug Product Database | B4-3688 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.